Latest Fibrodysplasia ossificans progressiva Stories
MONTREAL, April 2, 2015 /PRNewswire/ -- Clementia Pharmaceuticals, Inc. announced today that the Data Monitoring
Company to Host Webcast to Pay Tribute to FOP Community and Recognize Rare Disease Day MONTREAL, Feb.
Company Opens New Subsidiary to Serve U.S. Market MONTREAL, Jan.
MONTREAL, Dec. 1, 2014 /PRNewswire/ -- Clementia Pharmaceuticals, Inc. announced today that the U.S.
Researchers have developed a new way to study bone disorders and bone growth, using stem cells from patients afflicted with a rare, genetic bone disease.
Scientists have developed a new genetic approach to specifically block the damaged copy of the gene for a rare bone disease, while leaving the normal copy untouched.
- a slit in a tire to drain away surface water and improve traction.